Concept:
The chemical structure illustrated in the question represents the foundational nucleus of the Barbiturate chemical class. Structurally, barbiturates are cyclic derivatives of malonylurea, commonly referred to as barbituric acid (\(2,4,6\)-trioxohexahydropyrimidine). Barbituric acid itself lacks central nervous system (CNS) depressant activity because it is highly ionized at physiological pH and cannot effectively cross the lipophilic blood-brain barrier (BBB). To confer sedative-hypnotic activity, substitutions must be introduced at the C-5 position.
Let us evaluate the structural features and chemical classes of each given option:
• Option (A) zolpidem: Zolpidem is a non-benzodiazepine sedative-hypnotic drug belonging to the imidazopyridine chemical class. Its core consists of a fused imidazole and pyridine ring system. It lacks the six-membered tri-carbonyl pyrimidine ring entirely.
• Option (B) estazolam: Estazolam is a classic benzodiazepine derivative, specifically a triazolobenzodiazepine. Its structure features a benzene ring fused to a seven-membered diazepine ring, which is further fused to a five-membered triazole ring.
• Option (C) quazepam: Quazepam is also a member of the benzodiazepine class. It contains a trifluoroethyl group and a thiol/thione modification on the seven-membered ring system, distinctly separating it from the barbiturate family.
• Option (D) Pentobarbital: Pentobarbital is a classic barbiturate derivative. Its chemical structure features the exact pyrimidine-2,4,6-trione pharmacophore shown in the question. Specifically, it has an ethyl group and a 1-methylbutyl group substituted at the C-5 position. These hydrocarbon substitutions provide the ideal lipophilicity needed to penetrate the CNS and exert sedative-hypnotic actions via positive allosteric modulation of the \(\text{GABA}_\text{A}\) receptor complex.
Conclusion: Because the given structure is the defining skeleton of barbiturates, Pentobarbital is the only option that matches this pharmacophore.
